Twice-yearly injectable lenacapavir, an HIV-prevention drug, reduces risk by 96%
Gilead researchers say lenacapavir “has the potential to be one of the most impactful interventions” in the battle against HIV.
September 13, 2024
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Gilead researchers say lenacapavir “has the potential to be one of the most impactful interventions” in the battle against HIV.
A new pilot program that kicks off July 25 will offer free at-home HIV testing kits in seven Georgia Walmart stores.